Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Thalidomide, sold under the brand names Contergan, Distaval and Thalomid among others, is an oral administered medication currently used to treat a number of cancers (e.g., multiple myeloma), graft-versus-host disease, and many skin disorders (e.g., complications of leprosy such as skin lesions). Thalidomide has been used to treat conditions associated…
History, Community, Culture & Applications
Explore the main themes, entities and connections around Thalidomide. Start with the topic map, then use the sections below for research and deeper semantic analysis.
Start with a few of the strongest sections from the source topic. These are research directions, not a list of keywords you must use.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the full topic structure. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
See the strongest relationship patterns around the current topic before diving into the raw triples.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
drug effects birth pregnancy born use fda treatment women people us market defects teratogenic risk used many clinical cancer leprosy
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Thalidomide | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| Thalidomide | AHFS/Drugs.com | Monograph | 1.00 | infobox |
| Thalidomide | ATC code | L04AX02 (WHO) | 1.00 | infobox |
| Thalidomide | Bioavailability | 90% | 1.00 | infobox |
| Thalidomide | CAS Number | 50-35-1 Y | 1.00 | infobox |
| Thalidomide | ChEBI | CHEBI:9513 N | 1.00 | infobox |
| Thalidomide | ChEMBL | ChEMBL468 Y | 1.00 | infobox |
| Thalidomide | ChemSpider | 5233 Y | 1.00 | infobox |
| Thalidomide | Chirality | Racemic mixture | 1.00 | infobox |
| Thalidomide | CompTox Dashboard (EPA) | DTXSID9022524 | 1.00 | infobox |
| Thalidomide | DrugBank | DB01041 Y | 1.00 | infobox |
| Thalidomide | ECHA InfoCard | 100.000.029 | 1.00 | infobox |
| Thalidomide | Elimination half-life | 5–7.5 hours (dose-dependent) | 1.00 | infobox |
| Thalidomide | Excretion | Urine, feces and semen | 1.00 | infobox |
| Thalidomide | Formula | C13H10N2O4 | 1.00 | infobox |
| Thalidomide | IUPHAR/BPS | 7327 | 1.00 | infobox |
| Thalidomide | KEGG | D00754 Y | 1.00 | infobox |
| Thalidomide | Legal status | AU: S4 (Prescription only) | 1.00 | infobox |
| Thalidomide | Legal status | BR: Class C3 (Immunosuppressive drugs) | 1.00 | infobox |
| Thalidomide | Legal status | CA: ℞-only | 1.00 | infobox |
| Thalidomide | Legal status | UK: POM (Prescription only) | 1.00 | infobox |
| Thalidomide | Legal status | US: ℞-only | 1.00 | infobox |
| Thalidomide | Legal status | EU: Rx-only | 1.00 | infobox |
| Thalidomide | License data | EU EMA: by INN | 1.00 | infobox |
| Thalidomide | License data | US DailyMed: Thalidomide | 1.00 | infobox |
| Thalidomide | License data | US FDA: Thalidomide | 1.00 | infobox |
| Thalidomide | MedlinePlus | a699032 | 1.00 | infobox |
| Thalidomide | Melting point | 270 °C (518 °F) | 1.00 | infobox |
| Thalidomide | Metabolism | Liver (minimally via CYP2C19-mediated 5-hydroxylation; mostly via non-enzymatic hydrolysis at the four amide sites) | 1.00 | infobox |
| Thalidomide | Molar mass | 258.233 g·mol−1 | 1.00 | infobox |
These clusters group vocabulary that occurs around closely connected concepts in the source material.
Bridges can reveal useful research angles that are easy to miss in a flat list of related terms.